Organon BioSciences Overview
- Founded
-
1923

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
3
Organon BioSciences General Information
Description
Manufacturer of pharmaceutical products. The company develops, manufactures and markets products targeting selected therapeutic areas in human pharmaceuticals and covering a wide range of species in animal health. It offers its products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care and neuroscience, immunology, animal health and oncology.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Molenstraat 110
- 5342 CC Oss
- Netherlands
Organon BioSciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Organon BioSciences Patents
Organon BioSciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-131661-S | Slide case tablet dispenser | Inactive | 09-Jul-2009 | ||
US-D645244-S1 | Slide case tablet dispenser | Active | 09-Jul-2009 | ||
US-D645658-S1 | Slide case tablet dispenser | Active | 09-Jul-2009 | ||
US-D647295-S1 | Slide case tablet dispenser | Active | 09-Jul-2009 | ||
US-20090156569-A1 | Oral contraceptive spray | Inactive | 13-Dec-2007 | A61K31/56 |
Organon BioSciences Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Antonius Wilderbeek | President & Chief Executive Officer |
Organon BioSciences Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Organon BioSciences Investments & Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 & 000 | 13-Sep-2013 | 000000000 | Buildings and Property | ||
000 00000000 | 17-Apr-2008 | 0000000000 | Pharmaceuticals | ||
Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) | 26-Jun-2007 | Corporate Asset Purchase | Buildings and Property | 00000000 |
Organon BioSciences Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
000 00000000 | 17-Apr-2008 | 000000000000000000 | Completed |
|